Science

Pfizer Halves Initial Rollout of COVID-19 Vaccines Due to Logistics, Trial Issues

SHOT IN THE DARK

“Scaling up the raw material supply chain took longer than expected,” a company spokesperson told the Wall Street Journal.

GettyImages-1962556_jxksio
Scott Olson/Getty

Got a tip? Send it to The Daily Beast here.